SparingVision
FranceEntry
2020
Hold
6yr
Status
Active
Who owns SparingVision?
SparingVision is currently owned by 4Bio Partners through 4BIO Ventures III (2022 vintage), since 2020. Across its history, SparingVision has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
4Bio Partners4BIO Ventures III · 2022 · Life Sciences VC
4 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by AdBio Partners, Jeito Capital, 4Bio Partners and Ysios Capital Partners since 2019.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2019 · present
AdBio PartnersActive
2019 · present(7yr) · AFB Seed-Fund · 2017 · VC
4Bio PartnersActive
2020 · present(6yr) · 4BIO Ventures III · 2022 · Life Sciences VC
Jeito CapitalActive
2020 · present(6yr) · Jeito I · 2021 · VC
Ysios Capital PartnersActive
2022 · present(4yr) · Ysios BioFund III · 2020 · Life Sciences VC
More from 4BIO Ventures III
Other portfolio companies in the same fund.
UK
Switzerland
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track SparingVision
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy SparingVision?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on SparingVision.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue